Results 251 to 260 of about 134,446 (292)

CD19

1997
A. Neil Barclay, Marion H. Brown, S.K. Alex Law, Andrew J. McKnight, Michael G. Tomlinson, P. Anton van der Merwe   +5 more
openaire   +1 more source

CD19

1998
Tak W. Mak, Josef Penninger, John Roder, Janet Rossant, Mary Saunders   +4 more
openaire   +1 more source

Assessment and management of cytokine release syndrome and neurotoxicity following CD19 CAR-T cell therapy

Expert Opinion on Biological Therapy, 2020
Cameron J Turtle, Cassie K Chou
exaly  

Incidence of CD19-negative relapse after CD19-targeted immunotherapy in R/R BCP acute lymphoblastic leukemia: a review

Leukemia and Lymphoma, 2023
Renato Bassan, Hagop Kantarjian, Babatunde Adedokun   +2 more
exaly  

Phase IIa study of the CD19 antibody MOR208 in patients with relapsed or refractory B-cell non-Hodgkin’s lymphoma

Annals of Oncology, 2018
Mariano Provencio, Pier Luigi Zinzani, Tadeusz Robak   +2 more
exaly  

B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor–transduced T cells Free

Blood, 2012
James N Kochenderfer, Steven A Feldman, Mark E Dudley   +2 more
exaly  

Adoptive transfer of syngeneic T cells transduced with a chimeric antigen receptor that recognizes murine CD19 can eradicate lymphoma and normal B cells

Blood, 2010
James N Kochenderfer, Steven Rosenberg, Zhiya Yu   +2 more
exaly  

CD19

2016
openaire   +1 more source

CD19 variants

2019
LOBB ROY, RENNERT PAUL, HACKEL BENJAMIN, KLESMITH JUSTIN   +3 more
openaire   +4 more sources

Anti-CD19 antibodies

2009
HANSEN HANS J, QU ZHENGXING, GOLDENBERG DAVID M   +2 more
openaire   +12 more sources